Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242216471 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anja Feldmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Muenster University Children's Hospital, D-48149 Muenster, Germany. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Calcified aortic valve disease in its final stage leads to aortic valve stenosis, limiting cardiac function. To date, surgical intervention is the only option for treating calcific aortic valve stenosis. This study combined controlled drug delivery by nanoparticles (NPs) and active targeting by antibody conjugation. The chelating agent diethylenetriaminepentaacetic acid (DTPA) was covalently bound to human serum albumin (HSA)-based NP, and the NP surface was modified using conjugating antibodies (anti-elastin or isotype IgG control). Calcification was induced ex vivo in porcine aortic valves by preincubation in an osteogenic medium containing 2.5 mM sodium phosphate for five days. Valve calcifications mainly consisted of basic calcium phosphate crystals. Calcifications were effectively resolved by adding 1–5 mg DTPA/mL medium. Incubation with pure DTPA, however, was associated with a loss of cellular viability. Reversal of calcifications was also achieved with DTPA-coupled anti-elastin-targeted NPs containing 1 mg DTPA equivalent. The addition of these NPs to the conditioned media resulted in significant regression of the valve calcifications compared to that in the IgG-NP control without affecting cellular viability. These results represent a step further toward the development of targeted nanoparticular formulations to dissolve aortic valve calcifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, Muenster University Children's Hospital, D-48149 Muenster, Germany.
- International Network of Ectopic Calcification (INTEC), 9000 Ghent, Belgium.
- Institute of Pharmaceutical Technology and Biopharmacy, University of Muenster, D-48149 Muenster, Germany.
- Department of Orthopaedic Surgery, Otto-von-Guericke-University Magdeburg, D-39120 Magdeburg, Germany.
ORCID-Profile: Jessica Bertrand, Klaus Langer, Frank Rutsch
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Feldmann, A., Nitschke, Y., Linß, F., Mulac, D., Stücker, S., Bertrand, J., Buers, I., Langer, K., & Rutsch, F. (2023). Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216471
Vancouver
Feldmann A, Nitschke Y, Linß F, Mulac D, Stücker S, Bertrand J, et al. Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216471
BibTeX
@article{Feldmann2023,
author = {Feldmann, Anja and Nitschke, Yvonne and Linß, Franziska and Mulac, Dennis and Stücker, Sina and Bertrand, Jessica and Buers, Insa and Langer, Klaus and Rutsch, Frank},
title = {Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216471}
}
EUVIMED